Smad3 Promotes Cancer‐Associated Fibroblasts Generation via Macrophage–Myofibroblast Transition

Author:

Tang Philip Chiu‐Tsun12ORCID,Chung Jeff Yat‐Fai1,Xue Vivian Wei‐wen1,Xiao Jun2,Meng Xiao‐Ming3,Huang Xiao‐Ru24,Zhou Shuang5,Chan Alex Siu‐Wing6,Tsang Anna Chi‐Man1,Cheng Alfred Sze‐Lok7,Lee Tin‐Lap8,Leung Kam‐Tong9,Lam Eric W.‐F.10,To Ka‐Fai1,Tang Patrick Ming‐Kuen1,Lan Hui‐Yao211

Affiliation:

1. Department of Anatomical and Cellular Pathology State Key Laboratory of Translational Oncology The Chinese University of Hong Kong Hong Kong China

2. Department of Medicine and Therapeutics Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong China

3. School of Pharmacy Anhui Medical University An Hui China

4. Guangdong‐Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases Guangdong Academy of Medical Sciences Guangdong Provincial People's Hospital Guangzhou China

5. Department of Histology and Embryology Tongji University School of Medicine Tongji University Cancer Institute Shanghai China

6. Department of Applied Social Sciences The Hong Kong Polytechnic University Kowloon Hong Kong China

7. School of Biomedical Sciences The Chinese University of Hong Kong Hong Kong China

8. Reproduction Development and Endocrinology Program School of Biomedical Sciences The Chinese University of Hong Kong Hong Kong China

9. Department of Paediatrics Prince of Wales Hospital The Chinese University of Hong Kong Hong Kong China

10. Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat‐sen University Guangzhou Guangdong 510060 China

11. The Chinese University of Hong Kong‐Guangdong Academy of Sciences/Guangdong Provincial People's Hospital Joint Research Laboratory on Immunological and Genetic Kidney Diseases The Chinese University of Hong Kong Hong Kong China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3